WORK Medical Technology Group Limited Announces Over-Allotment Option Exercise
WORK Medical Technology Group LTD (Nasdaq: WOK), a leading provider of medical devices in China, has shared an important update concerning its initial public offering (the "Offering"). The underwriter has partially exercised its over-allotment option, resulting in the acquisition of an additional 91,942 ordinary shares at the public offering price of US$4.00 each. This strategic decision raises the total number of ordinary shares sold by the Company to 2,091,942, leading to gross proceeds of approximately $8.37 million before accounting for underwriting discounts and offering expenses.
Intended Use of Offering Proceeds
The funds raised from the Offering are earmarked for several vital initiatives that are essential for the Company's growth and operational effectiveness. These initiatives include upgrading production equipment to enhance capacity, developing a variety of masks and other medical consumables, and funding marketing activities for products. Additionally, a portion of the proceeds will be directed towards acquiring patents and general working capital to support the Company's overall corporate objectives.
Offering Structure and Underwriters
The Offering was arranged on a "firm commitment" basis, indicating the underwriter's obligation to purchase the shares offered. Kingswood Capital Partners, LLC (“Kingswood”) served as the sole book-running manager for the Offering, while Hunter Taubman Fischer & Li LLC and Ortoli Rosenstadt LLP acted as legal advisors for the Company and Kingswood, respectively.
Registration Statement and SEC Filing Details
A registration statement on Form F-1 pertaining to the Offering was properly filed with the U.S. Securities and Exchange Commission (the “SEC”). This document, identified as File Number: 333-271474, received effective approval from the SEC. It is important to highlight that the Offering was conducted exclusively through a prospectus that is part of the registration statement. Interested individuals can obtain copies of the final prospectus through Kingswood's office.
About WORK Medical Technology Group LTD
WORK Medical Technology Group LTD is well-known for its dedication to the development and manufacturing of Class I and II medical devices. The Company operates through subsidiaries in China and boasts a diverse product range that includes 21 distinct items, such as customized and multifunctional masks, along with various other medical consumables. Its products have been distributed across all 34 provincial-level administrative regions in China and are available in over 30 countries globally.
Quality and Regulatory Certifications
WORK Medical Technology Group has achieved numerous quality-related manufacturing designations, with 17 of its products registered with the U.S. Food and Drug Administration (FDA). This allows the Company to market its products in the competitive U.S. market, reflecting its commitment to quality and adherence to regulatory standards.
Contact Information
If you have any questions, please contact the Investor Relations Department of WORK Medical Technology Group LTD via email. The Company is committed to ensuring transparency and effective communication with its stakeholders.
WORK Medical Technology Group LTD
Investor Relations Department
Email: ir@workmedtech.com
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
Frequently Asked Questions
What is the main announcement from WORK Medical Technology Group LTD?
WORK Medical Technology Group LTD has announced the partial exercise of its underwriters’ over-allotment option, resulting in the sale of additional ordinary shares.
How much proceeds did the Company raise from the Offering?
The Offering raised approximately $8.37 million, increasing the total shares sold to 2,091,942 ordinary shares.
What will the proceeds from the Offering be used for?
The proceeds will be used for upgrading production facilities, developing new medical devices, marketing initiatives, patent acquisitions, and general corporate purposes.
Who managed the Offering?
Kingswood Capital Partners, LLC was the sole book-running manager for the Offering.
Where can one find more information about WORK Medical Technology Group's products?
For additional details on the products, please visit the Company’s official website.
